032566784	032566784	CD	B-NP	O
|	|	NN	I-NP	O
PH	PH	NN	I-NP	O
|	|	NN	I-NP	O
32147963	32147963	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
913523	913523	CD	B-NP	O
|	|	CC	I-NP	O
11/15/1995	11/15/1995	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/1995	10/6/1995	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/26/1995	8/26/1995	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
DEEP	DEEP	NN	B-NP	O
VENOUS	VENOUS	NN	I-NP	O
THROMBOSIS	THROMBOSIS	VBZ	B-VP	O
SECONDARY	SECONDARY	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
HEREDITARY	HEREDITARY	NN	B-NP	O
ANGIOEDEMA	ANGIOEDEMA	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73	73	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
white	white	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
30	30	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hereditary	hereditary	JJ	I-NP	O
angioedema	angioedema	NN	I-NP	O
attacks	attack	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
HAE	HAE	NN	B-NP	O
since	since	IN	B-PP	O
childhood	childhood	NN	B-NP	O
and	and	CC	O	O
recalls	recall	VBZ	B-VP	O
having	have	VBG	I-VP	O
a	a	DT	B-NP	O
ring	ring	NN	I-NP	O
cut	cut	VBD	B-VP	O
off	off	RP	B-PRT	O
her	her	PRP$	B-NP	O
finger	finger	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
child	child	NN	I-NP	O
during	during	IN	B-PP	O
an	an	DT	B-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
three	three	CD	B-NP	O
tracheostomies	tracheostomy	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
one	one	CD	I-NP	O
over	over	IN	B-PP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
for	for	IN	B-PP	O
laryngeal	laryngeal	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Symptoms	Symptom	NNS	B-NP	O
include	include	VBP	B-VP	O
throat	throat	NN	B-NP	O
tightness	tightness	NN	I-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
talking	talk	VBG	B-VP	O
and	and	CC	I-VP	O
swallowing	swallow	VBG	I-VP	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
often	often	RB	B-ADVP	O
has	have	VBZ	B-VP	O
attacks	attack	NNS	B-NP	O
at	at	IN	B-PP	O
local	local	JJ	B-NP	B-DNA
trauma	trauma	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
years	year	NNS	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
received	receive	VBN	I-VP	O
Human	Human	JJ	B-NP	B-protein
C1	C1	NN	I-NP	I-protein
esterase	esterase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
study	study	NN	I-NP	O
conducted	conduct	VBN	B-VP	O
at	at	IN	B-PP	O
CTMC	CTMC	NN	B-NP	B-protein
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Benjamin	Benjamin	NNP	I-NP	O
Gendusa	Gendusa	NNP	I-NP	O
She	She	NNP	I-NP	O
has	have	VBZ	B-VP	O
done	do	VBN	I-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
treatments	treatment	NNS	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
attacks	attack	NNS	I-NP	O
until	until	IN	B-PP	O
recently	recently	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
states	state	VBZ	B-VP	O
the	the	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
has	have	VBZ	B-VP	O
stopped	stop	VBN	I-VP	O
working	work	VBG	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Greg	Greg	NNP	I-NP	O
Toomsen	Toomsen	NNP	I-NP	O
has	have	VBZ	B-VP	O
told	tell	VBN	I-VP	O
her	her	PRP	B-NP	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
events	event	NNS	I-NP	O
include	include	VBP	B-VP	O
4/17	4/17	CD	B-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
flare	flare	NN	B-NP	O
of	of	IN	B-PP	O
HAE	HAE	NN	B-NP	B-protein
,	,	,	O	O
apparently	apparently	RB	B-ADVP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
acidemic	acidemic	JJ	I-ADJP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
to	to	TO	I-VP	O
laparotomy	laparotomy	VB	I-VP	O
emergently	emergently	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
pressors	pressor	NNS	B-NP	O
without	without	IN	B-PP	O
bowel	bowel	NN	B-NP	O
preparation	preparation	NN	I-NP	O
.	.	.	O	O

Colostomy	Colostomy	NN	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
for	for	IN	B-PP	O
bowel	bowel	NN	B-NP	O
wall	wall	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
requiring	require	VBG	B-VP	O
drainage	drainage	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
colostomy	colostomy	NN	I-NP	O
taken	take	VBN	B-VP	O
down	down	RP	B-PRT	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
incontinence	incontinence	NN	B-NP	O
of	of	IN	B-PP	O
stool	stool	NN	B-NP	O
requiring	require	VBG	B-VP	O
Depends	Depend	NNS	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
C4	C4	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
6-10	6-10	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
being	be	VBG	B-VP	O
16-34	16-34	CD	B-NP	O
,	,	,	O	O
C1	C1	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
5-9	5-9	CD	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-ADJP	O
being	be	VBG	B-VP	O
25-83	25-83	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/20/95	8/20/95	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
typical	typical	JJ	B-NP	O
HAE	HAE	NN	I-NP	O
attack	attack	NN	I-NP	O
with	with	IN	B-PP	O
crescendo	crescendo	NN	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	I-NP	O
throat	throat	NN	I-NP	O
tightness	tightness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
extra	extra	JJ	B-NP	O
stanozolol	stanozolol	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
persisted	persist	VBD	B-VP	O
to	to	TO	B-PP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
intolerable	intolerable	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
EW	EW	NN	I-NP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
was	be	VBD	B-VP	O
8/20/95	8/20/95	CD	B-NP	O
,	,	,	O	O
slightly	slightly	RB	B-NP	O
loose	loose	JJ	I-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
urine	urine	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
EW	EW	NNP	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Demerol	Demerol	NNP	B-NP	O
,	,	,	O	O
Solu	Solu	NNP	B-NP	O
Medrol	Medrol	NNP	I-NP	O
,	,	,	O	O
Zantac	Zantac	NNP	B-NP	O
and	and	CC	O	O
Benadryl	Benadryl	NNP	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
cholecystectomy	cholecystectomy	NN	B-NP	O
,	,	,	O	O
appendectomy	appendectomy	NN	B-NP	O
,	,	,	O	O
hysterectomy	hysterectomy	NN	B-NP	O
for	for	IN	B-PP	O
fibroid	fibroid	JJ	B-NP	O
,	,	,	I-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
bilateral	bilateral	JJ	I-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
calculi	calculus	NNS	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
cause	cause	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
AF	AF	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
DIG	DIG	NN	B-NP	B-protein
and	and	CC	I-NP	O
Verapamil	Verapamil	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	JJ	B-ADJP	O
post	post	IN	B-PP	O
subdural	subdural	JJ	B-NP	O
hematoma	hematoma	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
at	at	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
hypothyroid	hypothyroid	NN	B-NP	O
on	on	IN	B-PP	O
replacement	replacement	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
carpal	carpal	JJ	B-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
with	with	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
spine	spine	NN	I-NP	O
,	,	,	O	O
lumbosacral	lumbosacral	JJ	B-NP	O
spine	spine	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
involvement	involvement	NN	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
left	left	JJ	B-NP	O
iridectomy	iridectomy	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
drop	drop	NN	B-NP	O
foot	foot	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
thigh	thigh	JJ	B-NP	O
numbness	numbness	NN	I-NP	O
and	and	CC	I-NP	O
tingling	tingling	NN	I-NP	O
,	,	,	I-NP	O
dizziness	dizziness	NN	I-NP	O
and	and	CC	I-NP	O
disequilibrium	disequilibrium	NN	I-NP	O
.	.	.	O	O

FAMILY/SOCIAL	FAMILY/SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
son	son	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
grandchildren	grandchild	NNS	I-NP	O
with	with	IN	B-PP	O
HAE	HAE	NN	B-NP	B-protein
,	,	,	O	O
three	three	CD	B-NP	O
daughterse	daughterse	NN	I-NP	O
not	not	RB	B-VP	O
effected	effect	VBN	I-VP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
husband	husband	NN	B-NP	O
,	,	,	O	O
daughter	daughter	NN	B-NP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
upstairs	upstairs	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
uses	use	VBZ	B-VP	O
no	no	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
,	,	,	O	O
rare	rare	JJ	B-NP	O
ETOH	ETOH	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Digoxin	Digoxin	NN	B-NP	O
.125	.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Verapamil	Verapamil	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
0.05	0.05	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Stanozolol	Stanozolol	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Quinidine	Quinidine	NN	B-NP	O
causes	cause	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
;	;	:	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
;	;	:	O	O
propafenone	propafenone	NN	B-NP	O
,	,	,	O	O
migraines	migraine	NNS	B-NP	O
;	;	:	O	O
penicillin	penicillin	NN	B-NP	O
rash	rash	NN	I-NP	O
;	;	:	O	O
sulfa	sulfa	NN	B-NP	O
rash	rash	NN	I-NP	O
;	;	:	O	O
novocaine	novocaine	NN	B-NP	O
throat	throat	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Food	Food	NN	B-NP	O
allergies	allergy	NNS	I-NP	O
are	be	VBP	B-VP	O
wheat	wheat	NN	B-NP	O
,	,	,	O	O
dairy	dairy	NN	B-NP	O
,	,	,	O	O
chocolate	chocolate	NN	B-NP	O
,	,	,	O	O
walnuts	walnut	NNS	B-NP	O
and	and	CC	I-NP	O
strawberries	strawberry	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
ill-appearing	ill-appearing	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
raspy	raspy	NN	I-NP	O
voice	voice	NN	I-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
,	,	,	O	O
99.1	99.1	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
116	116	CD	I-NP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
132/84	132/84	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
normocephalic	normocephalic	JJ	B-NP	O
,	,	,	I-NP	O
atraumatic	atraumatic	JJ	I-NP	O
,	,	,	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
iridectomy	iridectomy	NN	I-NP	O
on	on	IN	B-PP	O
left	left	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
stridor	stridor	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
,	,	,	O	O
supple	supple	NN	B-NP	O
,	,	,	O	O
carotids	carotid	NNS	B-NP	B-protein
2	2	CD	B-NP	I-protein
+	+	SYM	B-NP	O
,	,	,	O	O
stigmata	stigma	NNS	B-NP	O
of	of	IN	B-PP	O
old	old	JJ	B-NP	O
thyroid	thyroid	NN	I-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
,	,	,	O	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

Heart	Heart	RB	B-ADVP	O
,	,	,	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
,	,	,	O	O
tachycardia	tachycardia	NN	B-NP	O
,	,	,	O	O
I/VI	I/VI	NN	B-NP	O
early	early	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
midline	midline	NN	I-NP	O
incision	incision	NN	I-NP	O
,	,	,	O	O
healing	healing	NN	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
but	but	CC	I-NP	O
exquisitely	exquisitely	RB	I-NP	O
tender	tender	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
or	or	CC	I-NP	O
percussion	percussion	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
positive	positive	JJ	B-NP	O
rebound	rebound	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
shake	shake	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
,	,	,	I-NP	O
guaiac	guaiac	JJ	I-NP	O
positive	positive	JJ	I-NP	O
per	per	IN	B-PP	O
EW	EW	NNP	B-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
pulses	pulse	NNS	B-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-VP	O
peripherally	peripherally	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
positive	positive	JJ	B-NP	O
pain	pain	NN	I-NP	O
to	to	TO	B-PP	O
passive	passive	JJ	B-NP	O
motion	motion	NN	I-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
not	not	RB	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

Neuro	Neuro	RB	B-ADVP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x	x	NN	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Motor	Motor	NNP	B-NP	O
is	be	VBZ	B-VP	O
5/5	5/5	CD	B-NP	O
throughout	throughout	IN	B-ADVP	O
except	except	IN	B-PP	O
left	left	JJ	B-NP	O
foot	foot	NN	I-NP	O
without	without	IN	B-PP	O
extension	extension	NN	B-NP	O
.	.	.	O	O

Sensory	Sensory	NNP	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
light	light	JJ	B-NP	O
touch	touch	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
,	,	,	O	O
deep	deep	JJ	B-NP	O
tendon	tendon	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
throughout	throughout	NN	I-NP	O
,	,	,	O	O
toes	toe	VBZ	B-VP	O
right	right	JJ	B-NP	O
upgoing	upgoing	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
downgoing	downgoe	VBG	I-VP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
count	count	NN	I-NP	O
10.2	10.2	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
41.3	41.3	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
377	377	CD	B-NP	I-protein
,	,	,	O	O
sodium	sodium	NN	B-NP	O
140	140	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.8	3.8	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
14	14	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
140	140	CD	I-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
13.5	13.5	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
24.5	24.5	CD	I-NP	I-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
and	and	CC	I-NP	O
KUB	KUB	NN	I-NP	B-protein
without	without	IN	B-PP	O
infiltrates	infiltrate	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
free	free	JJ	I-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ileus	ileus	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
117	117	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
QRS	QRS	NN	I-NP	B-protein
and	and	CC	I-NP	O
QT	QT	NN	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
10/10	10/10	CD	B-NP	O
,	,	,	O	O
DIG	DIG	NN	B-NP	O
effect	effect	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
improved	improve	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
improving	improve	VBG	B-VP	O
appetite	appetite	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
clear	clear	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
on	on	IN	B-PP	O
3/5/95	3/5/95	CD	B-NP	O
late	late	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
included	include	VBD	B-VP	O
Solu	Solu	NNP	B-NP	O
Medrol	Medrol	NNP	I-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
bolus	bolus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
and	and	CC	O	O
Stanozolol	Stanozolol	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
first	first	RB	B-ADVP	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
IV	IV	CD	B-NP	O
Zantac	Zantac	NN	I-NP	B-protein
50	50	CD	B-NP	I-protein
mg	mg	NN	I-NP	I-protein
q8	q8	NN	I-NP	I-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptoms	symptom	NNS	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
and	and	CC	O	O
diet	diet	NN	B-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
concerns	concern	NNS	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
were	be	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
ever	ever	RB	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
C1	C1	NN	I-NP	O
esterase	esterase	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
being	be	VBG	B-VP	O
was	be	VBD	I-VP	O
her	her	PRP$	B-NP	O
hypotension	hypotension	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	I-VP	O
bowel	bowel	VB	I-VP	O
surgery	surgery	NN	B-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
itself	itself	PRP	B-NP	O
or	or	CC	B-PP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
this	this	DT	B-NP	O
question	question	NN	I-NP	O
has	have	VBZ	B-VP	O
yet	yet	RB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
settled	settle	VBN	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Juengling	Juengling	NNP	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
left	left	JJ	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
by	by	IN	B-PP	O
10/6/95	10/6/95	CD	B-NP	O
and	and	CC	O	O
although	although	IN	B-SBAR	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
,	,	,	O	O
note	note	NN	B-NP	O
is	be	VBZ	B-VP	O
made	make	VBN	I-VP	O
of	of	IN	B-PP	O
past	past	JJ	B-NP	O
subdurals	subdural	NNS	I-NP	O
on	on	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
revealing	reveal	VBG	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bifurcation	bifurcation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
common	common	JJ	I-NP	O
and	and	CC	I-NP	O
superficial	superficial	JJ	I-NP	O
femorals	femoral	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
complications	complication	NNS	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
and	and	CC	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
filter	filter	NN	B-NP	O
placement	placement	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
2/14/95	2/14/95	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
complication	complication	NN	I-NP	O
of	of	IN	B-PP	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
said	say	VBD	B-VP	O
this	this	DT	B-NP	O
happens	happen	VBZ	B-VP	O
occasionally	occasionally	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
had	have	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
external	external	JJ	I-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sign	sign	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
internal	internal	JJ	I-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
gross	gross	JJ	I-NP	O
blood	blood	NN	I-NP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
coagulation	coagulation	NN	I-NP	O
studies	study	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
29.8	29.8	CD	B-NP	I-protein
on	on	IN	B-PP	O
10/26/95	10/26/95	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
overnight	overnight	RB	B-ADVP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	O	O
discharged	discharge	VBN	B-VP	O
on	on	IN	B-PP	O
11/7/95	11/7/95	CD	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Digoxin	Digoxin	NN	B-NP	O
.125	.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Synthroid	Synthroid	JJ	B-NP	O
50	50	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Verapamil	Verapamil	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Stanozolol	Stanozolol	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
followup	followup	VB	I-VP	O
by	by	IN	B-PP	O
telephone	telephone	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rosario	Rosario	NNP	I-NP	O
Manoso	Manoso	NNP	I-NP	O
CONDITION	CONDITION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Good	Good	NNP	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
JOHNSON	JOHNSON	NNP	B-NP	O
FORWOOD	FORWOOD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
XO24	XO24	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TITUS	TITUS	NNP	B-NP	O
DAUILA	DAUILA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
EH6	EH6	NNP	I-NP	O
QC714/1685	QC714/1685	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
5555	5555	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

FSOMYRFI9	FSOMYRFI9	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
8/8/95	8/8/95	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/5/95	10/5/95	CD	B-NP	O

